Q21LN7 AF NFT
tRNA (cytidine(34)-2'-O)-methyltransferase
MOLNFT AF v1 smart contract in GenesisL1 blockchain:
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eDIPFS of NFT metadata:
bafybeif7lgoy5epfvpcknpyh7t7vugyibhman6xuwkrrgj2uagv7wtbkx4/metadata.jsonIPFS of structure file:
bafybeihmkii2ykujbw2ealwog3jvkirgezvst5acpeiyzazjcirai4sx5q/AF-Q21LN7-F1-model_v2.pdbFirst NFT owner address (eip-55):
0x1d5DCa9830f6Ca963D9Bb5f9787E2AAfa85A53eAFirst NFT owner address (bech32):
genesis1r4wu4xps7m9fv0vmkhuhsl32475955l29zecrsCurrent NFT ID #475483 owner (web3):
First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER
MOLNFT Q21LN7 research and analysis (ICN3D with VR)
FASTA sequences
>sp|Q21LN7|TRML_SACD2 tRNA (cytidine(34)-2'-O)-methyltransferase OS=Saccharophagus degradans (strain 2-40 / ATCC 43961 / DSM 17024) OX=203122 GN=trmL PE=3 SV=2 MFNIVLFEPEIPPNTGNIIRVCANTGCRLHLIEPLGFELDDKRLRRAGLDYGEWQSVVTHANWDAFIKQQAPERLWALSTKGTKFHHEVSIGEGDYLVFGPETRGLPMEILEYITFDNVLRIPMLPNSRSMNLSNAASVMVYEAWRQLGFAGSK